Yixian Zhou,Guilan Quan,Qiaoli Wu,Xiaoxu Zhang,Boyi Niu,Biyuan Wu,Ying Huang,Xin Pan,Chuanbin Wu
Abstract:Mesoporous silica nanoparticles (MSNs) are attracting increasing interest for potential biomedical applications. With tailored mesoporous structure, huge surface area and pore volume, selective surface functionality, as well as morphology control, MSNs exhibit high loading capacity for therapeutic agents and controlled release properties if modified with stimuli-responsive groups, polymers or proteins. In this review article, the applications of MSNs in pharmaceutics to improve drug bioavailability, reduce drug toxicity, and deliver with cellular targetability are summarized. Particularly, the exciting progress in the development of MSNs-based effective delivery systems for poorly soluble drugs, anticancer agents, and therapeutic genes are highlighted.
What problem does this paper attempt to address?
The key problem that this paper attempts to solve lies in improving the efficiency of drug and gene delivery systems, especially for the delivery of poorly - soluble drugs, anti - cancer drugs and therapeutic genes. Specifically, the article explores the potential of mesoporous silica nanoparticles (MSNs) in biomedical applications, including the following aspects:
1. **Improving drug bioavailability**: Many new drug candidates show low water solubility, resulting in poor absorption. By loading these drugs into MSNs, their solubility and oral bioavailability can be improved.
2. **Reducing drug toxicity**: By controlling the drug release rate and targeted delivery, MSNs can reduce the toxicity of drugs to non - target cells or tissues.
3. **Achieving cell - targeted delivery**: By surface - modifying MSNs, such as binding specific ligands (e.g., folic acid, RGD peptides, etc.), efficient targeted delivery to specific cell types can be achieved, thereby improving the therapeutic effect and reducing side effects.
4. **Overcoming multidrug resistance (MDR)**: A common problem in cancer chemotherapy is that tumor cells develop resistance to multiple anti - cancer drugs. MSNs can overcome this obstacle through multiple mechanisms, such as increasing cell uptake, reducing the effect of drug efflux pumps, and co - delivering drugs that reverse MDR.
5. **Environment - responsive therapy**: Design "smart" MSNs with pH - sensitive, redox - sensitive, temperature - sensitive or enzyme - sensitive characteristics to achieve drug release under specific conditions in the tumor microenvironment, thereby increasing the local drug concentration and enhancing the curative effect.
6. **Gene delivery**: In addition to drug delivery, MSNs are also used for gene therapy as carriers to deliver therapeutic genes into target cells.
In summary, this review aims to summarize the research progress of effective delivery systems based on MSNs in recent years and look forward to its application prospects in the future biomedical field, especially its potential in solving the challenges of poorly - soluble drugs, anti - cancer drugs and therapeutic gene delivery.